Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
25.58%
60%
—
—
60%
—
5 Years
Score—
Net Growth25.58%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend60%
Revenue Consistency—
Taysha Gene Therapies Inc fundamental performance
Across Taysha Gene Therapies Inc's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 9M and net income went from -$ 43M to -$ 108M. Revenue increased in 50% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 6.41 | — |
1 Year2025-08-12 | $ 2.91 | 120.10% |
5 Years2021-08-12 | $ 17.47 | -63.34% |
All Time2020-09-24 | $ 24.06 | -73.38% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-09-24 |
|---|---|---|---|---|
| Price | $ 6.41 | $ 2.91 | $ 17.47 | $ 24.06 |
| Return | — | 120.10% | -63.34% | -73.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 7M | -$ 129M | $ 276M |
| 2025 | $ 9M | -$ 108M | $ 319M |
| 2024 | $ 8M | -$ 89M | $ 139M |
| 2023 | $ 15M | -$ 111M | $ 143M |
| 2022 | $ 2M | -$ 166M | $ 87M |
| 2021 | $ 0.00 | -$ 174M | $ 149M |
| IPO2020 | $ 0.00 | -$ 43M | $ 251M |
Explore beyond TSHA
You're looking at Taysha Gene Therapies Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
